Newsfeeds - Spark Newswire

2 minute read

The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week

Today, 8:12 PM

Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year.

ABOS

4 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 8:12 PM

Before 10 a.m. ET on Friday, 43 companies set new 52-week lows.

ACXP

4 minute read

The Daily Biotech Pulse: Iterum’s Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures

By Shanthi Rexaline

Today, 8:12 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1)

ALXN

1 minute read

Angion Stock Falls As Lead Product Candidate Flunks In COVID-19 Trial

By Vandana Singh

Today, 8:12 PM

Angion Biomedica Corp (NASDAQ: ANGN) has announced data from a small exploratory Phase 2 ALI-201 trial of ANG-3777 in patients with severe COVID-19 related pneumonia at high risk for acute respiratory distress syndrome (ARDS).

ANGN

5 minute read

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs

By Shanthi Rexaline

Today, 8:12 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29)

ACHL

3 minute read

Angion Announces Phase 2 ALI-201 Study Did Not Meet Primary Or Secondary Efficacy Endpoint

By Bill Haddad

Today, 8:12 PM

Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic

ANGN

4 minute read

The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus

By Shanthi Rexaline

Today, 8:12 PM

Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment.

AFMD